METHODS	In this 16-week , randomized , double-blind , placebo-controlled study , adults with type 2 diabetes ( hemoglobin A1c [ A1C ] values of 6.5 % to 10.0 % ) and hypercholesterolemia ( low-density lipoprotein cholesterol [ LDL-C ] levels > or = 100 mg/dL ) were randomly assigned ( 1:1 ) to colesevelam ( 3.75 g/d ) or placebo in combination with open-label metformin ( 850 mg/d ; uptitrated at week 2 to 1,700 mg/d ) .\